NOTOGINSENOSIDE R1 ATTENUATES RENAL ISCHEMIA-REPERFUSION INJURY IN RATS-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

NOTOGINSENOSIDE R1 ATTENUATES RENAL ISCHEMIA-REPERFUSION INJURY IN RATS

Published:2010-09 Issue:3 Volume:34 Page:314-320
ISSN:1073-2322
Container-title:Shock
language:en
Short-container-title:

Author:

Liu Wen-Jun,Tang Hong-Tai,Jia Yi-Tao,Ma Bing,Fu Jin-Feng,Wang Yu,Lv Kai-Yang,Xia Zhao-Fan

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Critical Care and Intensive Care Medicine,Emergency Medicine

Reference38 articles.

1. New cellular and molecular immune pathways in ischemia/reperfusion injury.;Boros;Am J Transplant,2006

2. Expression of CTL associated transcripts precedes the development of tubulitis in T-cell mediated kidney graft rejection.;Einecke;Am J Transplant,2005

3. Acute renal failure.;Thadhani;N Engl J Med,1996

4. Reperfusion injury in burned rats after delayed fluid resuscitation.;Xia;J Burn Care Rehabil,1991

5. Role of peroxynitrite on cytoskeleton alterations and apoptosis in renal ischemia reperfusion.;Vinas;Am J Physiol Renal Physiol,2007

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Traditional Chinese Medicine and renal regeneration: experimental evidence and future perspectives;Chinese Medicine;2024-06-03

2. Investigation of in Vitro Cytotoxic Activity and in Vivo Anti-Tumor Activity in Tumor-Causing Mice with 7,12-Dimethyl-benz[1]anthracene of Vietnamese Processed Panax notoginseng;Natural Product Communications;2024-06

3. Using Pharmacokinetic–Pharmacodynamic Modeling to Study the Main Active Substances of the Anticancer Effect in Mice from Panax ginseng–Ophiopogon japonicus;Molecules;2024-01-09

4. Nrf2/HO-1 as a therapeutic target in renal fibrosis;Life Sciences;2023-12

5. Immunomodulatory, Anti-Inflammatory, and Anti-Cancer Properties of Ginseng: A Pharmacological Update;Molecules;2023-05-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3